ULIXE CORP. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ULIXE CORP. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | ($129.1K) | Oct 9, 2024 |
| FY2024 | Jul 31, 2023 | ($84.4K) | Oct 9, 2024 |
| FY2023 | Jul 31, 2022 | ($382.3K) | Feb 1, 2024 |
| FY2022 | Jul 31, 2021 | ($20.2K) | Sep 15, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | ($82.8K) | Oct 9, 2024 |
| FY2024 | Jul 31, 2023 | ($188.3K) | Oct 9, 2024 |
| FY2023 | Jul 31, 2022 | ($555.1K) | Feb 1, 2024 |
| FY2022 | Jul 31, 2021 | $276.4K | Sep 15, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | $237.2K | Oct 9, 2024 |
| FY2024 | Jul 31, 2023 | $215.0K | Oct 9, 2024 |
| FY2023 | Jul 31, 2022 | $346.3K | Feb 1, 2024 |
| FY2022 | Jul 31, 2021 | $356.3K | Sep 15, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | $81.3K | Oct 9, 2024 |
| FY2024 | Jul 31, 2023 | $35.0K | Oct 9, 2024 |
| FY2023 | Jul 31, 2022 | $138.8K | Feb 1, 2024 |
| FY2022 | Jul 31, 2021 | $331.6K | Sep 15, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | $155.9K | Oct 9, 2024 |
| FY2024 | Jul 31, 2023 | $180.0K | Oct 9, 2024 |
| FY2023 | Jul 31, 2022 | $207.4K | Feb 1, 2024 |
| FY2023 | Jul 31, 2021 | $24.7K | Feb 1, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | ($616.0K) | Oct 9, 2024 |
| FY2024 | Jul 31, 2023 | ($486.9K) | Oct 9, 2024 |
| FY2023 | Jul 31, 2022 | ($402.5K) | Feb 1, 2024 |
| FY2022 | Jul 31, 2021 | ($20.2K) | Sep 15, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | $39 | Oct 9, 2024 |
| FY2024 | Jul 31, 2023 | $16 | Oct 9, 2024 |
| FY2023 | Jul 31, 2022 | $13.1K | Feb 1, 2024 |
| FY2023 | Jul 31, 2021 | $17.2K | Feb 1, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | 0 | Oct 9, 2024 |
| FY2024 | Jul 31, 2023 | 0 | Oct 9, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | 139.94M | Oct 9, 2024 |
| FY2024 | Jul 31, 2023 | 239.59M | Oct 9, 2024 |
| FY2023 | Jul 31, 2022 | 239.37M | Feb 1, 2024 |
| FY2022 | Jul 31, 2021 | 242.04M | Sep 15, 2022 |